Novartis AG (NYSE:NVS – Get Free Report) was the target of some unusual options trading activity on Tuesday. Investors acquired 54,767 call options on the stock. This represents an increase of 2,389% ...
North America Vision Care market is estimated to be valued at US$ 6.44 Bn in 2023 and is expected to exhibit a CAGR of 4.5% during the forecast period 2023-2030 Mr. Shah Coherent Market Insights Pvt.
Moderna Inc., a biotechnology and pharmaceutical company reorienting its business for a post-pandemic age, awarded almost $17 ...
Cambridge, Massachusetts Thursday, March 13, 2025, 10:00 Hrs [IST] ...
CAMBRIDGE, MA, USA I March 11, 2025 I Biogen Inc. (Nasdaq: BIIB) – announced the initiation of dosing in the global clinical study, TRANSCEND. The Phase ...
Nasal Polyps Treatment Market Research Report The global nasal polyps treatment market is expected to reach around $4,243.9 million by 2030 ...
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
High-dose vitamin D supplementation reduces disease activity in clinically isolated syndrome typical of MS, results of a ...
19h
GlobalData on MSNBiogen begins dosing in trial of felzartamab for kidney transplant patients with AMRIn Part A of the trial, subjects will be given nine intravenous infusions of either the drug or placebo over a six-month period.
In the trials, omalizumab and multi-allergen oral immunotherapy showed alike efficacy in protecting against food allergies, ...
PARIS] Ozempic-maker Novo Nordisk is planning to make more of its medicines for the US market in the country; Boeing risks a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results